SUSTAINED GONADAL SUPPRESSION IN FERTILE WOMEN WITH THE LHRH AGONIST BUSERELIN
- 1 November 1983
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 19 (5) , 613-617
- https://doi.org/10.1111/j.1365-2265.1983.tb00039.x
Abstract
Nine fertile women were treated with the LHRH agonist buserelin (7 women received 800 .mu.g, 2 women 1200 .mu.g intranasally for up to 24 wk). Both doses produced sustained suppression of ovarian function accompanied by hot flushes. In 5 women chemical castration was established within 1 to 5 wk, while in the other 4 volunteers transient peaks of serum estradiol occurred between the 6th and 19th wk. Thereafter low postmenopausal estradiol levels persisted. Chemical castration was confirmed by hormonal parameters and endometrial biopsies (inactive endometrium). After cessation of treatment normla cyclical function occurred immediately. This reversible chemical castration may be useful for new therapeutical approaches in sexual hormone dependent diseases (endometriosis, precocious puberty, metastatic breast cancer).Keywords
This publication has 6 references indexed in Scilit:
- SUSTAINED SUPPRESSION OF TESTOSTERONE PRODUCTION BY THE LUTEINISING-HORMONE RELEASING-HORMONE AGONIST BUSERELIN IN PATIENTS WITH ADVANCED PROSTATE CARCINOMAThe Lancet, 1982
- Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?Contraception, 1981
- Decreased Pituitary Responsiveness and Inhibition of the Luteinizing Hormone Surge and Ovulation in the Stumptailed Monkey (Macaca arctoides) by Chronic Treatment with an Agonist of Luteinizing Hormone-Releasing HormoneEndocrinology, 1980
- Inhibition of ovulation in women by chronic treatment with a stimulatory lrh analogue — A new approach to birth control?Contraception, 1978
- Serum profile of gonadotropins and ovarian steroids in women during six months of treatment with ORG 485-50Contraception, 1977